Lee's Pharmaceutical Holdings Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lee's Pharmaceutical Holdings Ltd with three other
companies in this sector in Hong Kong:
Dawnrays Pharmaceutical Holdings Ltd
sales of 1.12 billion Hong Kong Dollars [US$144.61 million]
of which 78%
was Finished Drugs),
Beijing Tong Ren Tang Chinese Medicine Company Limited
(1.51 billion Hong Kong Dollars [US$194.88 million]
of which 53%
was Healthcare products and Chinese medicine), and
Golden Throat Holdings Group Co Ltd
(821.79 million Hong Kong Dollars [US$105.79 million]
Lee's Pharmaceutical Holdings Ltd reported sales of HK$1.14 billion (US$146.45 million)
December of 2018.
increase of 12.8%
versus 2017, when the company's sales were HK$1.01 billion.
This was the third consecutive year of growth at Lee's Pharmaceutical Holdings Ltd.
Sales of License-In Products saw an increase
13.5% in 2018, from
HK$544.40 million to HK$618.07 million.